D. Moir

M. Tucker, H. Pass, J. Nesbitt, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Strategies for Large‐Insert Cloning and Analysis

Douglas R. Smith, D. Moir, 2007 .

Adjunctive therapy for multidrug-resistant bacterial infections: type III secretion system and efflux inhibitors.

D. Moir, T. Opperman, T. Bowlin, 2021, Drug discovery today.

Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata.

J. Fletcher, K. Montgomery, S. Weremowicz, 1995, Genomics.

Rapid identification of overlapping YACs in the MEN2 region of human chromosome 10 by hybridization with Alu element-mediated PCR products.

D. Housman, D. Bowden, V. Stanton, 1993, Gene.

Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosa.

Richard A. Moore, H. Schweizer, D. Moir, 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

A High-Throughput, Homogeneous, Bioluminescent Assay for Pseudomonas aeruginosa Gyrase Inhibitors and Other DNA-Damaging Agents

H. Schweizer, D. Moir, T. Opperman, 2007, Journal of biomolecular screening.

Molecular cloning and characterization of double-stranded cDNA coding for bovine chymosin.

G. Vovis, D. Moir, J. Schumm, 1982, Gene.

Amplification of large artificial chromosomes.

Douglas R. Smith, D. Smith, D. Moir, 1990, Proceedings of the National Academy of Sciences of the United States of America.

An Essential DnaB Helicase of Bacillus anthracis: Identification, Characterization, and Mechanism of Action

S. Biswas, D. Moir, M. Barnes, 2008, Journal of bacteriology.

A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface.

D. Moir, Britney Johnson, Gai Liu, 2017, ACS infectious diseases.

Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.

D. Moir, S. Bavari, N. Peet, 2010, Journal of medicinal chemistry.

Characterization of a nonglycosylated single chain urinary plasminogen activator secreted from yeast.

D. Moir, G. Avgerinos, D. Dumais, 1990, The Journal of biological chemistry.

Determination of the order of gene function in the yeast nuclear division pathway using cs and ts mutants.

D. Botstein, D. Moir, 1982, Genetics.

Heterologous protein secretion from yeast.

R. Smith, D. Moir, M. Duncan, 1985, Science.

Structure of the human receptor tyrosine phosphatase gamma gene (PTPRG) and relation to the familial RCC t(3;8) chromosome translocation.

K. Huebner, D. Moir, J. Lasota, 1996, Genomics.

Identiﬁcation of a Small-Molecule Entry Inhibitor for Filoviruses (cid:1)

R. Ray, D. Moir, M. Farzan, 2011 .

Identification of inhibitors of bacterial enoyl-acyl carrier protein reductase.

D. Moir, 2005, Current drug targets. Infectious disorders.

Novel Broad-Spectrum Bis-(Imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains

R. Ulrich, R. Gussio, D. Moir, 2009, Antimicrobial Agents and Chemotherapy.

Synthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS).

Carson M. Brown, D. Moir, D. Aiello, 2015, Bioorganic & medicinal chemistry.

Development and Application of a Cellular, Gain-of-Signal, Bioluminescent Reporter Screen for Inhibitors of Type II Secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei

Richard A. Moore, H. Schweizer, D. Moir, 2011, Journal of biomolecular screening.

Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.

D. Moir, S. Bavari, N. Peet, 2010, Bioorganic & medicinal chemistry.

Aryl Rhodanines Speciﬁcally Inhibit Staphylococcal and Enterococcal Bioﬁlm Formation (cid:1) †

D. Moir, N. Peet, T. Opperman, 2009 .

A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.

D. Le Paslier, D. Ward, R. Spritz, 1994, Genomics.

Small molecule compounds that inhibit antioxidant response gene expression in an inducer-dependent manner.

R. Plemper, Julien Sourimant, D. Moir, 2020, ACS infectious diseases.

Production of proteins by secretion from yeast.

D. Moir, L. Davidow, 1991, Methods in enzymology.

Potent and broad-spectrum antibacterial activity of indole-based bisamidine antibiotics: synthesis and SAR of novel analogs of MBX 1066 and MBX 1090.

D. Moir, S. Nguyen, S. Bavari, 2013, Bioorganic & medicinal chemistry.

Comparative In Vitro Activity Profiles of Novel Bis-Indole Antibacterials against Gram-Positive and Gram-Negative Clinical Isolates

D. Moir, S. Bavari, N. Peet, 2010, Antimicrobial Agents and Chemotherapy.

The yeast secretory pathway is perturbed by mutations in PMR1, a member of a Ca2+ ATPase family

G. Fink, J. Mao, D. Moir, 1989, Cell.

Expression of calf prochymosin in Saccharomyces cerevisiae.

R. Smith, D. Moir, T. Kohno, 1984, Gene.

Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activities.

D. Moir, D. Aiello, N. Peet, 2012, Journal of medicinal chemistry.

Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.

S. Biswas, D. Moir, D. Aiello, 2009, Bioorganic & medicinal chemistry.

Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion

S. Lory, D. Moir, D. Aiello, 2010, Antimicrobial Agents and Chemotherapy.

Genomics and Antimicrobial Drug Discovery

G. Vovis, D. Moir, K. Shaw, 1999, Antimicrobial Agents and Chemotherapy.

Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.

M. Relling, D. Moir, M. Relling, 1994, Human molecular genetics.

Identification of a Small-Molecule Entry Inhibitor for Filoviruses

R. Ray, D. Moir, M. Farzan, 2011, Journal of Virology.

Mapping cDNAs by Hybridization to Gridded Arrays of DNA from YAC Clones

P. Richterich, G. Vovis, Douglas R. Smith, 1994 .

The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase.

P. Nowell, C. Croce, H. Alder, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Helicobacter pylori Physiology Predicted from Genomic Comparison of Two Strains

G. Vovis, E. Brown, D. Moir, 1999, Microbiology and Molecular Biology Reviews.

Strategies for Large‐Insert Cloning and Analysis

Douglas R. Smith, D. Moir, 1998 .

Strategies for Large‐Insert Cloning and Analysis

Douglas R. Smith, D. Moir, 1998 .

Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls.

H. Issaq, D. Moir, N. Caporaso, 1997, Lung cancer.

Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations.

P. Nowell, C. Croce, G. Cimino, 1991, Cancer research.

Cold-sensitive cell-division-cycle mutants of yeast: isolation, properties, and pseudoreversion studies.

D. Botstein, D. Moir, B. Osmond, 1982, Genetics.

Yeast mutants with increased secretion efficiency.

D. Moir, 1989, Biotechnology.

Whole-Transcriptome Shotgun Sequencing thailandensis SOS Response by Using Characterization of the Burkholderia

R. Ulrich, D. DeShazer, D. Moir, 2014 .

Characterization of the Burkholderia thailandensis SOS Response by Using Whole-Transcriptome Shotgun Sequencing

R. Ulrich, M. Ulrich, D. DeShazer, 2013, Applied and Environmental Microbiology.

New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion

D. Moir, A. Basu, Lijun Rong, 2013, Journal of Virology.

Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection

D. Moir, A. Hauser, Katherine R. Murphy, 2017, Antimicrobial Agents and Chemotherapy.

Novel Small Molecule Entry Inhibitors of Ebola Virus.

J. Dye, A. Herbert, K. Chandran, 2015, The Journal of infectious diseases.

Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.

J. Mecsas, D. Moir, A. Hauser, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A human genome YAC library in a selectable high-copy-number vector.

D. Smith, D. Moir, A. P. Smyth, 1993, Gene.

Toward a physical map of human chromosome 10: isolation of 183 YACs representing 80 loci and regional assignment of 94 YACs by fluorescence in situ hybridization.

N. Ma, D. Moir, J. C. Day, 1994, Genomics.

Genomics and New Technologies Applied to Antibacterial Drug Discovery

D. Moir, 2002 .

Aryl Rhodanines Specifically Inhibit Staphylococcal and Enterococcal Biofilm Formation

D. Moir, N. Peet, T. Opperman, 2009, Antimicrobial Agents and Chemotherapy.

Structural basis foractivation of the titin kinasedomain duringmyo ® brillogenesis

O. Mayans, G. Vovis, Douglas R. Smith, 2022 .

Discovery of Bacterial Fatty Acid Synthase Type II Inhibitors Using a Novel Cellular Bioluminescent Reporter Assay

C. Rock, D. Moir, D. M. Mills, 2015, Antimicrobial Agents and Chemotherapy.

Burkholderia pseudomallei and Pseudomonas aeruginosa Type II Secretion in Development and Application of a Cellular , Gain-of-Signal , Bioluminescent Reporter Screen for Inhibitors of

Richard A. Moore, H. Schweizer, D. Moir, 2011 .

Vibrational fingerprinting of bacterial pathogens by surface enhanced Raman scattering (SERS)

W. Ranjith Premasiri, Lawrence D. Ziegler, D. T. Moir, 2005, SPIE Defense + Commercial Sensing.

New Small Molecule Entry Inhibitors Targeting 1 Hemagglutinin-mediated Influenza A Virus Fusion 2 3

Barnard, D. Moir, A. Basu, 2013 .

Mutations in the Pseudomonas aeruginosa Needle Protein Gene pscF Confer Resistance to Phenoxyacetamide Inhibitors of the Type III Secretion System

J. Mecsas, D. Moir, D. Aiello, 2014, Antimicrobial Agents and Chemotherapy.

Design, synthesis and activities of 4/5-acyl-2-aminoimidazolyl analogues of oroidin for biofilm inhibition

D. Moir, T. Opperman, S. Cai, 2013 .

DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics

D. Moir, D. Aiello, E. Long, 2016, Antimicrobial Agents and Chemotherapy.

Bis-imidazolinylindoles are active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Mycobacterium tuberculosis

D. Moir, S. Bavari, R. Panchal, 2012, The Journal of Antibiotics.

Development of 124 sequence-tagged sites and cytogenetic localization of 217 cosmids for human chromosome 10.

D. Bowden, T. Keith, N. Ma, 1994, Genomics.

Characterization of a flow-sorted human chromosome 10 cosmid library by FISH.

J. Longmire, L. Deaven, N. Ma, 1996, Cytogenetics and cell genetics.

Potent and broad-spectrum antibacterial activity of indole-based bisamidine antibiotics: synthesis and SAR of novel analogs of MBX 1066 and MBX 1090.

D. Moir, S. Nguyen, S. Bavari, 2013, Bioorganic & medicinal chemistry.

Cloning ofALL-1, the Locus Involved in Leukemias with the t(4;ll)(q21;q23), t(9;ll)(p22;q23), and t(ll;19)(q23;pl3) Chromosome Translocations1

E. Canaani, D. Moir, S. Katzav, 2006 .

Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.

J. Mecsas, D. Moir, A. Hauser, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimization of pro‐urokinase secretion from recombinant Saccharomyces cerevisiae

D. Moir, G. Avgerinos, L. Melnick, 1991, Biotechnology and bioengineering.

Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.

S. Biswas, D. Moir, D. Aiello, 2009, Bioorganic & medicinal chemistry.